Safety and efficacy of concurrent carboplatin during full-dose craniospinal irradiation for high-risk/metastatic medulloblastoma in a resource-limited setting.

Tejpal GuptaShwetabh SinhaGirish ChinnaswamyTushar VoraPrasad MayaVasudev BhatJayant Sastri GodaRahul KrishnatryAbhishek ChatterjeeSridhar EpariAyushi SahayAliasgar MoiyadiPrakash ShettyVijay PatilSoumen Khatua Rakesh JalaliPurna Kurkure

Published in: Pediatric blood & cancer (2021)

Addition of concurrent carboplatin to RT as radiosensitizing chemotherapy is a simple and effective way of treatment intensification in high-risk/metastatic medulloblastoma.

Keyphrases

locally advanced
phase ii study
squamous cell carcinoma
small cell lung cancer
rectal cancer
radiation therapy
phase iii
radiation induced
open label